Koyfin Home > Directory > Health Care > Acorda Therapeutics > EBIT

Acorda Therapeutics EBIT Chart (ACOR)

Acorda Therapeutics annual/quarterly EBIT from 2010 to 2020. Earnings before interest and taxes measures the profit a company generates from its operations, making it synonymous with operating profit. By ignoring tax and interest expenses, it focuses solely on a company's ability to generate earnings from operations, ignoring variables such as the tax burden and capital structure.
  • Acorda Therapeutics EBIT for the quarter ending June 06, 2020 was $-25m a -32.83% increase of 8m year over year
  • Acorda Therapeutics EBIT for the last 12 months ending June 06, 2020 was $-101m a -18.23% increase of 18m year over year
  • Acorda Therapeutics Annual EBIT for 2019 was $-117m a 181.29% decrease of -211m from 2018
  • Acorda Therapeutics Annual EBIT for 2018 was $95m a -18.63% decrease of -18m from 2017
  • Acorda Therapeutics Annual EBIT for 2017 was $112m a 108.70% increase of 122m from 2016
Other Income Statement Metrics:
  • Acorda Therapeutics EBITDA for the quarter ending December 12, 2018 was $-14m a 190.76% decrease of -26m year over year
  • Acorda Therapeutics Net Income for the quarter ending December 12, 2018 was $10m a 185.45% increase of 18m year over year
  • Acorda Therapeutics Total Revenue for the quarter ending December 12, 2018 was $69m a -53.52% decrease of -37m year over year
View Chart On Koyfin

Quarterly ACOR EBIT Data

06/2020$-25m
03/2020$-32m
12/2019$-12m
09/2019$-33m
06/2019$-36m
03/2019$-36m
12/2018$-15m
09/2018$51m
06/2018$52m
03/2018$7m

Annual ACOR EBIT Data

2019$-117m
2018$95m
2017$112m
2016$-10m
2015$45m
2014$46m
2013$31m
2012$26m
2011$49m
2010$-8m